Join this Medilink Midlands webinar in partnership with Frost & Sullivan ‘Reimaging healthcare post COVID-19’.
As healthcare businesses, organisations and governments work to determine what course of action needs to be taken in a post-pandemic world, Frost & Sullivan has mobilised its global resources to provide comprehensive scenario based analysis on the future growth and opportunities in the healthcare industry. This analysis will provide stakeholders with sector insights to guide economic development, collaboration/partnership and company targeting efforts.
This webinar will cover:
* How will the current market turmoil impact business planning?
* What are the scenarios in the market which will influence strategy?
* What are the best practices and recommendations for business survival?
* What growth opportunities exist in the market and how organisations can leverage them?
There will be an opportunity to ask any questions in a Q&A session following the presentations.
Siddharth Saha, Vice President:Healthcare Research
Siddharth Saha, MHM, BSc. is the Vice President of Research for the Medical Technologies program area within Frost & Sullivan’s Healthcare practice. In this role, Siddharth’s main function is providing thought leadership and big picture business implications of research conclusions to commercial and executive teams within stakeholder organisations in the healthcare space. Apart from providing operational and commercial leadership for the research business within the healthcare practice, he also uses his experience in hospital operational issues, clinical workflows and real time healthcare industry analysis to design, execute and deliver professional services based on actionable market insights and advisory services. Siddharth has a passion for analysing the role of technology and innovative business models in solving the myriad of challenges the healthcare industry currently faces. He works closely with leading medical OEM’s, ICT firms, technology start-ups, new entrants in the value chain and, the investment community, as they assess commercially sustainable value propositions in the healthcare business sector.
Unmesh Lal, Industry Principal: Life Sciences
Unmesh has 15+ years of healthcare industry expertise, comprising of strategy consulting, primarily with global pharmaceutical companies. His particular expertise lies in tracking game changing companies, innovative business models and disruptive technologies in the digital transformation of the life sciences industry. He has engaged with European clients across key healthcare sectors from pharmaceuticals and biotechnology to clinical diagnostics and clinical research. His thought leadership and in-depth understanding of the precision health ecosystem enable him to guide companies in identifying growth opportunities in key segments like life sciences IT, personalized therapeutics and contract services. He is author of the ‘Post-pandemic Global Healthcare Market Outlook’ research analyses and holds a Master degree in Biomedical Engineering from the University of Michigan- Ann Arbor.
Chandni Mathur, Senior Industry Analyst: Transformational Health
Chandni Mathur is a seasoned healthcare strategist and consultant with over 11 years of experience across large, global consulting firms and in the healthcare provider space in India and in the UAE. She is currently serving as a Senior Industry Analyst in the Digital Health program at Frost & Sullivan.